Hypervision Surgical

About Hypervision Surgical Hypervision Surgical (“Hypervision”) is a spin-out from King’s College London, founded by clinicians and experts in medical imaging and artificial intelligence. Using safe light alone, our mission is to equip surgeons with real-time, AI-driven tissue intelligence to improve precision and patient safety. We are pioneering the world’s first regulatory-cleared real-time intraoperative spectral imaging platform, combining on-chip spectral sensing with high-speed AI analytics at over 60 frames per second. Seamlessly integrating into existing surgical vision systems, our technology transforms standard cameras into intelligent, data-rich tools — revealing anatomical, physiological, and pathological information beyond human vision. Certified for both open and minimally invasive surgery, our platform achieved UKCA certification and FDA clearance in 2025 under a newly established AI/ML product code, and was admitted into the FDA’s Safer Technology Program. With multi-centre clinical evaluations underway and strategic partnerships with world-leading technology and surgical manufacturers, including imec and ZEISS Ventures, Hypervision is shaping the future of data-driven surgery.